Lupin Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LUPIN PHARMS
LUPIN PHARMS has eleven approved drugs.
There are two tentative approvals on LUPIN PHARMS drugs.
Drugs and US Patents for Lupin Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Pharms | DROXIDOPA | droxidopa | CAPSULE;ORAL | 211652-001 | Feb 18, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Lupin Pharms | RIFAMPIN | rifampin | CAPSULE;ORAL | 090034-002 | Aug 21, 2013 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lupin Pharms | DESLORATADINE | desloratadine | TABLET;ORAL | 078352-001 | Oct 25, 2010 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lupin Pharms | SUPRAX | cefixime | FOR SUSPENSION;ORAL | 065129-001 | Feb 23, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Lupin Pharms | ZIPRASIDONE HYDROCHLORIDE | ziprasidone hydrochloride | CAPSULE;ORAL | 077560-002 | Mar 2, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for LUPIN PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Oral Suspension | 500 mg/5 mL | ➤ Subscribe | 2014-07-22 |
Similar Applicant Names
Here is a list of applicants with similar names.

